A Partner in Health
A new chapter, a new approach. Collaborating with physicians and other healthcare professionals, focusing on R&D and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Work with Us
Join Covidien, where we appreciate your talent, your experience and your passion for your work. Our culture thrives because we invest in our colleagues' growth and reward their efforts.
Visit Us
Covidien Imaging Solutions will be at the Radiological Society of North America meeting in Chicago from November 30 – December 4, 2008. Click here to learn more about our full line of contrast media and delivery systems solutions.
COV (NYSE)
| Price: | $34.24 |
| Change: | (1.03) |
| Volume: | 4,380,449 |
Minimum 20 minute delay
-
11/19/2008 12:02:00 PM
Covidien Launches Improved Magellan Safety Hypodermic Needle
Company Also Appealed Jury Finding of Infringement MANSFIELD, Mass., Nov 19, 2008 (BUSINESS WIRE) -- Covidien (NYSE: COV; BSX: COV), a leading global provider of healthcare products, today announced that it is launching a new and improved Magellan(TM) Safety Hy... -
11/17/2008 6:02:00 AM
Covidien Reports Fourth-Quarter and Fiscal 2008 Results
--Fourth-quarter net sales up 12%, led by double-digit increases in Medical Devices, Pharmaceutical Products and Medical Supplies
--Fourth-quarter diluted GAAP earnings per share from continuing operations were $0.82; excluding specified items, adjust...
-
11/11/2008 7:01:00 AM
BOULDER, Colo.--(BUSINESS WIRE)--Nov. 11, 2008--A two-year randomized study just published in the peer-reviewed journal CHEST (November 2008) demonstrates that continuous aspiration of subglottic secretions (CASS) (1) significantly reduced ant...
-
11/5/2008 4:02:00 PM
Covidien to Present at Credit Suisse Healthcare Conference
HAMILTON, Bermuda--(BUSINESS WIRE)--Nov. 5, 2008--Covidien Ltd. (NYSE: COV, BSX: COV) will present at the Credit Suisse 2008 Annual Healthcare Conference in Phoenix, Arizona, on November 12, 2008. Richard J. Meelia, Chairman, President and Chief Executive Officer, will discuss the Company...